Revamped Pharmaceutical Technology Upgradation Assistance Scheme (RPTUAS)

What it is

Facilitate existing pharmaceutical units in upgrading manufacturing technology and facilities to meet Revised Schedule M and WHO-GMP standards.

What you get

• Capital subsidy of 10% to 20% of eligible pharmaceutical-upgradation investment, subject to INR 2 crore maximumUp to ₹2,00,00,000

Who it is for

• Existing pharmaceutical manufacturing unit with a proven operating track record
• Average turnover for the preceding three years must be below INR 500 crore
• Unit must be upgrading toward Revised Schedule M and/or WHO-GMP standards
• Eligible expenditure must be incurred after 01 January 2024
• Current scheme intake and shortlisted-applicant status must be confirmed from the Department/SIDBI route
• CA-certified expenditure and the applicable regulatory certificate are required for staged claims

How to apply

1. 1
   Confirm current intake and applicant boundary

   Check with the Department of Pharmaceuticals or SIDBI that applications are being accepted for your unit's category.

   Official step
2. 2
   Classify turnover and eligible investment

   Calculate the preceding-three-year average turnover and isolate post-01 January 2024 expenditure in eligible activities and production equipment.

3. 3
   Prepare certification and technical dossier

   Prepare the CA-certified expenditure statement, project or gap-analysis material and the Revised Schedule M/WHO-GMP certification sequence required by the current modification.

   Official step
4. 4
   Submit through the verified official route

   Submit your dossier on the official Department/SIDBI scheme portal, then track the technical review, the Scheme Steering Committee decision and the staged release of funds.

   Official step

Keep ready